Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients-Reference-Cited by-同舟云学术

Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients

Published:2023-01-20 Issue:6 Volume:38 Page:1567-1570
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Cheng Yuan¹^ORCID,Xiang Qiong¹²,Cao Tao¹,Tang Fei¹,Chen Jia¹,Qi Dongli¹,Hu Haofei¹,Song Haiying¹,Chang Zheyi¹,Ku Ming¹,Chen Xinglin³,Chen Chi⁴,Wan Qijun¹

Affiliation:

1. Department of Nephrology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University , Shenzhen, Guangdong , P.R. China

2. Shantou University Medical College , Shantou, Guangdong , P.R. China

3. Department of Epidemiology and Biostatistics, Empower U, X&Y Solutions Inc. , Boston, MA , USA

4. Department of Immunology and Microbiology, Guiyang College of Traditional Chinese Medicine , Guiyang, Guizhou , China

Funder

Basic Research Program of the Shenzhen Science and Technology R&D Fund

Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project

Shenzhen Key Medical Discipline Construction Fund

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfad017/49880969/gfad017.pdf

Reference17 articles.

1. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target;Am J Kidney Dis,2007

2. Anaemia management and mortality risk in chronic kidney disease;Hörl;Nat Rev Nephrol,2013

3. Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients;Besarab;Nephrol Dial Transplant,2015

4. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD;Gupta;Am J Kidney Dis,2017

5. Roxadustat treatment for anemia in patients undergoing long-term dialysis;Chen;N Engl J Med,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between roxadustat use and suppression of thyroid function: a systematic review and meta-analysis;Journal of Pharmaceutical Health Care and Sciences;2024-06-08

2. A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat;Journal of Nephrology;2024-01-08

3. Effects of roxadustat on thyroid hormone levels and blood lipid metabolism in patients undergoing hemodialysis: a retrospective study;International Journal of Medical Sciences;2024

4. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2023-10